Financière de Tubize S.A. Financière de Tubize S.A.

Financière de Tubize S.A.

TUB

Classement en actions #2128
Financière de Tubize SA, headquartered in Brussels, Belgium, operates as a... Financière de Tubize SA, headquartered in Brussels, Belgium, operates as a global biopharmaceutical firm, primarily through its investment in UCB. The company is dedicated to discovering and advancing innovative medicines and solutions focused on neurological and immunological disorders. Its current commercial offerings include Cimzia, an established treatment for a range of inflammatory conditions such as ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis. For partial-onset seizures in epilepsy, it provides Briviact, Vimpat, and Keppra, alongside Nayzilam, a nasal spray. Neupro addresses Parkinson's disease and restless legs syndrome. Additionally, the portfolio features Evenity, an injectable therapy for osteoporosis, and Bimzelx, used to manage moderate to severe plaque psoriasis. The company's development pipeline highlights several promising candidates: Staccato, aimed at stereotypical prolonged seizures; Bepranemab for Alzheimer's disease; and UCB0599 for Parkinson's disease. Other therapies under investigation include bimekizumab, which targets psoriasis, psoriatic arthritis, hidradenitis suppurativa, and axial spondyloarthritis; rozanolixizumab, for conditions like myasthenia gravis, immune thrombocytopenia, myelin oligodendrocyte glycoprotein antibody disease, and autoimmune encephalitis; and dapirolizumab pegol, intended for systemic lupus erythematosus.
Prix de l'action
$215.64
Capitalisation boursière
$9.60B
Changement (1 jour)
-1.73%
Changement (1 an)
-20.72%
Pays
BE
Échange Financière de Tubize S.A. (TUB)

Catégorie

Healthcare
Historique du rendement du dividende pour Financière de Tubize S.A. (TUB)
Le rendement du dividende (TTM) de Financière de Tubize S.A. (symbole boursier : TUB) au 2023-12-31 est : 1.20%
Rendement moyen du dividende sur les 5 dernières années : 0.89%
Historique du rendement du dividende de Financière de Tubize S.A. (TUB) de 2003 à 2026
Rendement du dividende à la fin de chaque année (TTM)
Année Rendement du dividende Changez
2026 (TTM) 0.65% -4.41%
2024 0.68% -43.33%
2023 1.20% 13.21%
2022 1.06% 41.33%
2021 0.75% 0.00%
2020 0.75% -14.77%
2019 0.88% -1.12%
2018 0.89% 12.66%
2017 0.79% -5.95%
2016 0.84% 18.31%
2015 0.71% -21.98%
2014 0.91% -10.78%
2013 1.02% -31.54%
2012 1.49% -24.75%
2011 1.98% -9.59%
2010 2.19% 10.61%
2009 1.98% -45.30%
2008 3.62% 146.26%
2007 1.47% 75.00%
2006 0.84% 154.55%
2005 0.33% -73.60%
2004 1.25% -19.35%
2003 1.55% 0.00%
Rendements du dividende (TTM) pour des entreprises similaires ou concurrentes
Entreprise Rendement du dividende Pays
0.00%
US
0.00%
US
2.17%
AU
0.00%
CH
0.00%
NL